{
    "root": "2fbde52f-ab78-eee0-e063-6294a90aefe7",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Montelukast Sodium",
    "value": "20250307",
    "ingredients": [
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14077"
        },
        {
            "name": "HYPROMELLOSE 2910 (6 MPA.S)",
            "code": "0WZ8WG20P6",
            "drugbank_id": "https://go.drugbank.com/drugs/DB11075"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32234"
        },
        {
            "name": "POLYETHYLENE GLYCOL 6000",
            "code": "30IQX730WE",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_13643"
        },
        {
            "name": "FERRIC OXIDE RED",
            "code": "1K09F3G675",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_50819"
        },
        {
            "name": "FERRIC OXIDE YELLOW",
            "code": "EX438O2MRT",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_50819"
        },
        {
            "name": "MONTELUKAST SODIUM",
            "code": "U1O3J18SFL",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_6993"
        },
        {
            "name": "CROSCARMELLOSE SODIUM",
            "code": "M28OL1HH48"
        },
        {
            "name": "HYDROXYPROPYL CELLULOSE (TYPE L)",
            "code": "UKE75GEA7F",
            "drugbank_id": "https://go.drugbank.com/drugs/DB00840"
        }
    ],
    "indications": {
        "text": "montelukast sodium tablets leukotriene receptor antagonist indicated : prophylaxis chronic treatment asthma patients 15 years age older ( 1.1 ) . acute prevention exercise-induced bronchoconstriction ( eib ) patients 15 years age older ( 1.2 ) . relief symptoms allergic rhinitis ( ar ) : seasonal allergic rhinitis ( sar ) patients 15 years age older , perennial allergic rhinitis ( par ) patients 15 years age older . reserve patients inadequate response intolerance alternative therapies ( 1.3 ) . limitations : indicated treat acute asthma attack ( 5.2 ) .",
        "doid_entities": [
            {
                "text": "asthma (DOID:2841)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_2841"
            },
            {
                "text": "exercise-induced bronchoconstriction (DOID:0080821)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_0080821"
            },
            {
                "text": "allergic rhinitis (DOID:4481)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_4481"
            },
            {
                "text": "rhinitis (DOID:4483)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_4483"
            },
            {
                "text": "acute asthma (DOID:0080810)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_0080810"
            }
        ],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "( ) : asthma : daily evening patients 15 years older ( 2.1 ) . acute prevention eib : 10 mg tablet least 2 hours exercise patients 15 years age older ( 2.2 ) . seasonal allergic rhinitis : daily patients 15 years older ( 2.3 ) . perennial allergic rhinitis : daily patients 15 years older ( 2.3 ) . ( age ) : 15 years older : one 10-mg tablet ( 2 ) . patients asthma allergic rhinitis take one dose daily evening ( 2.4 ) .",
        "doid_entities": [
            {
                "text": "asthma (DOID:2841)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_2841"
            },
            {
                "text": "seasonal allergic rhinitis (DOID:4481)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_4481"
            },
            {
                "text": "rhinitis (DOID:4483)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_4483"
            }
        ],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "montelukast sodium tablets , usp 10 mg beige colored , rounded square , biconvex , film coated tablet debossed \u201c m10 \u201d one side plain side . supplied follows : ndc 16729-119-10 unit high-density polyethylene ( hdpe ) bottles 30 polypropylene child-resistant cap , aluminum foil induction seal , silica gel desiccant . ndc 16729-119-15 unit high-density polyethylene ( hdpe ) bottles 90 polypropylene child-resistant cap , aluminum foil induction seal , silica gel desiccant . ndc 16729-119-17 high-density polyethylene ( hdpe ) bottles 1000 polypropylene non child-resistant cap , aluminum foil induction seal , silica gel desiccant . storage store montelukast sodium tablets , usp 10 mg film-coated 20\u00b0c 25\u00b0c ( 68\u00b0f 77\u00b0f ) , excursions permitted 15\u00b0c 30\u00b0c ( 59\u00b0f 86\u00b0f ) [ usp controlled room temperature ] . protect moisture light . store original package .",
    "adverseReactions": "montelukast sodium tablets contraindicated patients hypersensitivity components .",
    "indications_original": "Montelukast sodium tablets are a leukotriene receptor antagonist indicated for: Prophylaxis and chronic treatment of asthma in patients 15 years of age and older ( 1.1 ). Acute prevention of exercise-induced bronchoconstriction (EIB) in patients 15 years of age and older ( 1.2 ). Relief of symptoms of allergic rhinitis (AR): seasonal allergic rhinitis (SAR) in patients 15 years of age and older, and perennial allergic rhinitis (PAR) in patients 15 years of age and older. Reserve use for patients who have an inadequate response or intolerance to alternative therapies ( 1.3 ). Limitations of Use: Not indicated to treat an acute asthma attack ( 5.2 ).",
    "contraindications_original": "Administration (by indications): Asthma: Once daily in the evening for patients 15 years and older ( 2.1 ). Acute prevention of EIB: 10 mg tablet at least 2 hours before exercise for patients 15 years of age and older ( 2.2 ). Seasonal allergic rhinitis: Once daily for patients 15 years and older ( 2.3 ). Perennial allergic rhinitis : Once daily for patients 15 years and older ( 2.3 ). Dosage (by age): 15\u00a0years and older: one 10-mg tablet ( 2 ). Patients with both asthma and allergic rhinitis should take only one dose daily in the evening ( 2.4 ).",
    "warningsAndPrecautions_original": "Montelukast sodium tablets, USP 10 mg are beige colored, rounded square, biconvex, film coated tablet debossed \u201cM10\u201d on one side and plain on other side. They are supplied as follows:\n                  NDC 16729-119-10 unit of use high-density polyethylene (HDPE) bottles of 30 with a polypropylene child-resistant cap, an aluminum foil induction seal, and silica gel desiccant.\n                  NDC 16729-119-15 unit of use high-density polyethylene (HDPE) bottles of 90 with a polypropylene child-resistant cap, an aluminum foil induction seal, and silica gel desiccant.\n                  NDC 16729-119-17 high-density polyethylene (HDPE) bottles of 1000 with a polypropylene non child-resistant cap, an aluminum foil induction seal, and silica gel desiccant.\n                  Storage\n                  Store montelukast sodium tablets, USP 10 mg film-coated at 20\u00b0C to 25\u00b0C (68\u00b0F to 77\u00b0F), excursions permitted to 15\u00b0C to 30\u00b0C (59\u00b0F to 86\u00b0F) [see USP Controlled Room Temperature]. Protect from moisture and light. Store in original package.",
    "adverseReactions_original": "Montelukast sodium tablets are contraindicated in patients with hypersensitivity to any of its components.",
    "drug": [
        {
            "name": "Montelukast Sodium",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_6993"
        }
    ]
}